NDC 68258-3030

RELENZA

Zanamivir

RELENZA is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Dispensing Solutions Inc.. The primary component is Zanamivir.

• Product ID: 68258-3030_342b7e19-49d6-4d0b-950a-cc00f4b79924
• NDC: 68258-3030
• Product Type: Human Prescription Drug
• Proprietary Name: RELENZA
• Generic Name: Zanamivir
• Dosage Form: Powder
• Route of Administration: RESPIRATORY (INHALATION)
• Marketing Start Date: 2002-12-22
• Marketing Category: NDA / NDA
• Application Number: NDA021036
• Labeler Name: Dispensing Solutions Inc.
• Substance Name: ZANAMIVIR
• Active Ingredient Strength: 5 mg/1
• Pharm Classes: Neuraminidase Inhibitor [EPC],Neuraminidase Inhibitors [MoA]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 68258-3030-1

5 PACKAGE in 1 CARTON (68258-3030-1) > 4 POWDER in 1 PACKAGE

• Marketing Start Date: 2002-12-22
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 68258-3030-1 [68258303001]

RELENZA POWDER

• Marketing Category: NDA
• Application Number: NDA021036
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2002-12-22
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
ZANAMIVIR	5 mg/1

OpenFDA Data

• SPL SET ID: 12ff22f6-20b5-4fa8-9028-58f87e169ff5
• Manufacturer:
  • Dispensing Solutions Inc.
• UNII:
  • L6O3XI777I
• RxNorm Concept Unique ID - RxCUI:
  • 759471
  • 759473

Pharmacological Class

• Neuraminidase Inhibitor [EPC]
• Neuraminidase Inhibitors [MoA]

NDC Crossover Matching brand name "RELENZA" or generic name "Zanamivir"

NDC	Brand Name	Generic Name
0173-0681	RELENZA	zanamivir
68258-3030	RELENZA	zanamivir